Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05963971 · ClinicalTrials.gov registry record · NA

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

A NA study of Obesity and Acute Lymphoblastic Leukemia, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
376
Enrollment target
1
Study location

NCT05963971 is a NA study of Obesity and Acute Lymphoblastic Leukemia that is actively recruiting participants, run by Columbia University. The registered enrollment target is 376 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05963971, a NA study of Obesity and Acute Lymphoblastic Leukemia, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
376 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (ALL).

Interventions

  • OTHER Standard of care
  • BEHAVIORAL PEDALL

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 376 participants
Start Date 2024-03-19
Est. Completion 2027-06-23
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05963971

The ClinicalTrials.gov registry entry for NCT05963971 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (54% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT05963971 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05963971 about?

NCT05963971 is a clinical study titled "A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors". The purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (ALL).

What is the current status of trial NCT05963971?

This trial is currently recruiting. It is a NA study. The enrollment target is 376 participants. The study started on 2024-03-19. Estimated completion is 2027-06-23.

What conditions does trial NCT05963971 study?

This clinical trial studies the following conditions: Obesity, Acute Lymphoblastic Leukemia.

What interventions are being tested in trial NCT05963971?

The interventions under investigation include: Standard of care (OTHER), PEDALL (BEHAVIORAL).

Who is sponsoring clinical trial NCT05963971?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05963971 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.